Salute e Benessere
Change in the Sobi Board of Directors
Sobi®
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across
Europe , North America , the
Middle East , Asia and
Australia . In 2024, revenue amounted to
SEK 26 billion . Sobi's share (STO: SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
Contacts
For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here.
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/swedish-orphan-biovitrum-ab/r/change-in-the-sobi-board-of-directors,c4253684
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/change-in-the-sobi-board-of-directors-302590090.html